Ruby Chandy Elected to AMETEK Board of Directors

               Ruby Chandy Elected to AMETEK Board of Directors

PR Newswire

BERWYN, Pa., May 9, 2013

BERWYN, Pa., May 9, 2013 /PRNewswire/ --AMETEK, Inc. (NYSE: AME) today
announced that the Company's stockholders have elected Ruby Chandy to its
Board of Directors. Ms. Chandy currently is President of Pall Industrial, a
$1.3 billion division of Pall Corporation.

"We are very pleased to welcome Ruby to AMETEK's Board of Directors. She is
an experienced business leader with a strong strategic and marketing
background across a number of industrial and technology businesses. Her
contributions to the Company and the Board should significantly benefit the
continued growth of AMETEK," commented Frank S. Hermance, AMETEK Chairman and
Chief Executive Officer.

Ms. Chandy has extensive experience in general management, marketing and
strategy. She joined Pall Corporation in her current position in 2012 and is a
member of its Executive Management Team. She also has held leadership
positions at Dow Chemical Company, Thermo Fisher Scientific, Boston
Scientific, Millipore Corporation and McKinsey & Co.

Prior to joining Pall, Ms. Chandy most recently led the Dow Plastics Additives
Business and served as Chief Marketing Officer for Dow Chemical. In her
general management and marketing roles, Ms. Chandy has specialized in driving
growth through global strategy deployment, new product innovation, business
development and market expansion.

Ms. Chandy is a graduate of the Massachusetts Institute of Technology, where
she earned a Bachelor's Degree in Materials Science and Engineering and a
Master's Degree in Business. She also holds a Master's Degree in Materials
Science and Engineering from Northwestern University

Corporate Profile
AMETEK is a leading global manufacturer of electronic instruments and
electro-mechanical devices with annualized sales of $3.5 billion. AMETEK's
Corporate Growth Plan is based on Four Key Strategies: Operational Excellence,
Strategic Acquisitions, Global & Market Expansion and New Products. AMETEK's
objective is double-digit percentage growth in earnings per share over the
business cycle and a superior return on total capital. The common stock of
AMETEK is a component of the S&P MidCap 400 and the Russell 1000 Indices.

Forward-looking Information
Statements in this news release relating to future events, such as AMETEK's
expected business and financial performance are "forward-looking statements."
Forward-looking statements are subject to various factors and uncertainties
that may cause actual results to differ significantly from expectations. These
factors and uncertainties include AMETEK's ability to consummate and
successfully integrate future acquisitions; risks associated with
international sales and operations; AMETEK's ability to successfully develop
new products, open new facilities or transfer product lines; the price and
availability of raw materials; compliance with government regulations,
including environmental regulations; changes in the competitive environment or
the effects of competition in our markets; the ability to maintain adequate
liquidity and financing sources; and general economic conditions affecting the
industries we serve. A detailed discussion of these and other factors that
may affect our future results is contained in AMETEK's filings with the U.S.
Securities and Exchange Commission, including its most recent reports on Form
10-K, 10-Q and 8-K. AMETEK disclaims any intention or obligation to update or
revise any forward-looking statements.

Contact: Kevin C. Coleman (610) 889-5247


Press spacebar to pause and continue. Press esc to stop.